Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 27c, provides guidance
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
General and administrative: 1.42M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
General and administrative: 1.42M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q3 EPS of $0.57, $0.27 better than the analyst estimate of $0.30. Revenue for the quarter came in at $128.7 million versus the consensus estimate of $123.41 million.
GUIDANCE:
Catalyst Pharmaceuticals sees FY2024 revenue of $475-485 million, versus the consensus of $473.7 million.
For earnings history and earnings-related data on Catalyst Pharmaceuticals (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
- Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
